Alvotech
NASDAQ:ALVODrug Manufacturers - Specialty & Generic
-$0.04 today
- Market cap
- $1.62B
- Beta
- 0.21
- P/E (TTM)
- -15.9
- EPS (TTM)
- -$0.24
Volume 1.56M
Average 0.65M
ALVO Total Current Liabilities
All obligations due within one year.
AlvotechNASDAQ: ALVO
Total Current Liabilities · Q1 FY2026 · quarter ended Mar 2026
Total current liabilities falls 2.3% from a year ago
Total current liabilities stood at $259.78M at the end of Q1 FY2026, down 2.3% from a year earlier and down 14.6% from the prior quarter. Over 3 fiscal years it compounded at +22.0% a year.
Context
- Total current liabilities amounted to 18.3% of total assets at the end of Q1 FY2026, down 3.1 pp from a year earlier.
- Total current liabilities increased in 2 of the last 3 fiscal years.
- FY2025 was the highest annual figure in the 4 fiscal years shown.
What to watch
Whether total current liabilities keeps falling in the next quarterly balance sheet after a -2.3% change from a year earlier.
Sources:Balance SheetText generated from reported figures; not investment advice.
Total Current Liabilities history
USD · from the balance sheet
- Latest · FY2025
- 304.08M USD
- Year-over-year change
- +57.2%
- 4-year CAGR
- +28.4%
| Period | Period end | Total Current Liabilities | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 304.08M | +57.2% |
| FY2024 | 2024-12-31 | 193.4M | -25.9% |
| FY2023 | 2023-12-31 | 260.95M | +56.0% |
| FY2022 | 2022-12-31 | 167.29M | +49.6% |
| FY2021 | 2021-12-31 | 111.84M | — |
Total Current Liabilities vs competitors
How ALVO compares with its peers on the latest reported figures
- ALVO's Mar 2026 total current liabilities of $259.78M is the 8th highest of the 11 companies compared; the peer median is $1.77B.
- Its year-over-year change of -2.3% is the 7th highest of 11, against a peer median of +11.0%.
- Total current liabilities amounts to 18.3% of total assets for ALVO, versus a peer median of 22.6%.
| Company | Period | Latest balance | YoY | 3-year CAGR | % of assets |
|---|---|---|---|---|---|
| Jun 2026 | $25.5B | +24.5% | +17.6% | 26.7% | |
| Jun 2026 | $15.65B | +31.9% | +5.5% | 39.3% | |
| Jun 2026 | $5.53B | +50.8% | +11.6% | 13.3% | |
| Jun 2026 | $3.92B | +23.0% | +0.8% | 12.2% | |
| Sep 2026 | $2.65B | -1.0% | -1.6% | 19.8% | |
| Jun 2026 | $883.19M | -20.2% | +5.4% | 23.4% | |
| Mar 2026 | $434.97M | -10.6% | +0.5% | 26.3% | |
| Mar 2026 | $259.78M | -2.3% | +22.0% | 18.3% | |
| Mar 2026 | $164.48M | -17.4% | +18.6% | 10.0% | |
| Mar 2026 | $91.44M | -51.1% | +72.9% | 21.8% | |
| Mar 2026 | $44.18M | +74.3% | +81.3% | 45.2% | |
| Peer median (excluding ALVO) | $1.77B | +11.0% | +8.5% | 22.6% | |
Competitors are the stored peer set for ALVO. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Balance Sheet
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Cash & Equivalents | 17.56M | 66.43M | 11.16M | 51.43M | 172.36M |
| Short-term Investments | 0 | 0 | 0 | 0 | 0 |
| Net Receivables | 53.88M | 71.39M | 87.22M | 251.72M | 153.79M |
| Inventory | 39.06M | 71.47M | 74.43M | 127.89M | 220.05M |
| Other Current Assets | 0 | 851K | 0 | 0 | 0 |
| Total Current Assets | 119.82M | 230.74M | 194.84M | 455.02M | 574.02M |
| Property, Plant & Equipment (Net) | 205.33M | 268.1M | 356.58M | 409.74M | 356.4M |
| Goodwill | 12.37M | 11.64M | 12.06M | 11.33M | 12.84M |
| Intangible Assets | 21.51M | 25.65M | 19.08M | 20.62M | 81.83M |
| Long-term Investments | 55.31M | 48.57M | 18.49M | 22.71M | 122.93M |
| Tax Assets | 170.42M | 209.5M | 309.81M | 298.36M | 192.21M |
| Other Non-current Assets | 13.23M | 34.25M | 39.23M | 3.62M | 146.87M |
| Total Non-current Assets | 478.16M | 597.71M | 755.25M | 766.38M | 913.08M |
| Total Assets | 597.98M | 828.44M | 950.09M | 1.22B | 1.49B |
| Account Payables | 28.59M | 49.19M | 80.56M | 67.13M | 126.12M |
| Short-term Debt | 2.77M | 19.92M | 38.03M | 32.7M | 36.92M |
| Tax Payables | 841K | 934K | 925K | 204K | 1.04M |
| Deferred Revenue | 29.69M | 36.92M | 59.18M | 15.98M | 30.36M |
| Other Current Liabilities | 5.26M | 17.46M | 34.5M | 6.63M | 13.7M |
| Total Current Liabilities | 111.84M | 167.29M | 260.95M | 193.4M | 304.08M |
| Long-term Debt | 398.14M | 744.65M | 922.13M | 1.04B | 1.26B |
| Deferred Tax Liabilities | 150K | 309K | 53K | 1.81M | 7.87M |
| Deferred Revenue (Non-current) | 44.84M | 57.02M | 73.26M | 80.72M | 5.5M |
| Other Non-current Liabilities | 63.77M | 388.22M | 520.55M | 210.22M | 53.99M |
| Total Non-current Liabilities | 621.75M | 1.23B | 1.62B | 1.44B | 1.47B |
| Total Liabilities | 733.59M | 1.39B | 1.88B | 1.63B | 1.77B |
| Common Stock | 135K | 2.13M | 2.28M | 2.83M | 2.93M |
| Retained Earnings | (1.14B) | (1.65B) | (2.21B) | (2.44B) | (2.41B) |
| Accumulated OCI | 4.67M | 29.14M | 41.38M | 15.05M | 16.68M |
| Other Stockholders Equity | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 |
| Total Equity | (135.61M) | (564.42M) | (932.49M) | (412.77M) | (284.49M) |
| Total Debt | 523.05M | 805.1M | 1.08B | 1.19B | 1.45B |
| Net Debt | 505.5M | 738.68M | 1.06B | 1.14B | 1.28B |
Alvotech
NASDAQ:ALVO
Intrinsic Alpha fair value
Locked
Current Price
$4.55
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.